Home Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Hepatology 2012 (546 pages, free PDF)
Hepatitis C 2012 (150 pages, free PDF)
Free Medical Books

  Breast Cancer

  Free Subscription


07.05.2012

2 AJR Am J Roentgenol
1 Am J Pathol
4 Ann Oncol
3 Arch Intern Med
1 BMC Cancer
1 BMJ
2 Br J Cancer
5 Breast Cancer Res
3 Breast Cancer Res Treat
1 Cancer
2 Cancer Cell
2 Cancer Epidemiol Biomarkers Prev
2 Cancer Lett
1 Clin Cancer Res
1 Eur J Cancer
1 Int J Cancer
1 Int J Oncol
2 Int J Radiat Oncol Biol Phys
3 J Biol Chem
1 J Clin Oncol
3 J Natl Cancer Inst
1 JAMA
2 Lancet
2 N Engl J Med
2 Oncogene
2 Oncol Rep
1 Oncology
3 PLoS One
1 Radiology


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. HIRANO M , Satake H, Ishigaki S, Ikeda M, et al
    Diffusion-weighted imaging of breast masses: comparison of diagnostic performance using various apparent diffusion coefficient parameters.
    AJR Am J Roentgenol. 2012;198:717-22.
    PubMed     Text format     Related articles    Abstract available


  2. NISHIKAWA RM , Schmidt RA, Linver MN, Edwards AV, et al
    Clinically missed cancer: how effectively can radiologists use computer-aided detection?
    AJR Am J Roentgenol. 2012;198:708-16.
    PubMed     Text format     Related articles    Abstract available



    Am J Pathol

  3. RAPPA G , Mercapide J, Lorico A
    Spontaneous Formation of Tumorigenic Hybrids between Breast Cancer and Multipotent Stromal Cells Is a Source of Tumor Heterogeneity.
    Am J Pathol. 2012.
    PubMed     Text format     Related articles    Abstract available



    Ann Oncol

  4. BOEHMER U , Timm A, Ozonoff A, Potter J, et al
    Explanatory factors of sexual function in sexual minority women breast cancer survivors.
    Ann Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available


  5. VILLARREAL-GARZA C , Cortes J, Andre F, Verma S, et al
    mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directions.
    Ann Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available


  6. MUNZONE E , Botteri E, Esposito A, Sciandivasci A, et al
    Outcome and clinical-biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastases.
    Ann Oncol. 2012.
    PubMed     Text format     Related articles    Abstract available


  7. BONNEFOI H , Macgrogan G
    Endocrine-responsive breast cancer special types: who cares?
    Ann Oncol. 2012.
    PubMed     Text format     Related articles   



    Arch Intern Med

  8. KEEN JD , Keen J
    Screen detection has both winners and losers.
    Arch Intern Med. 2012;172:447.
    PubMed     Text format     Related articles   


  9. ONITILO AA
    The debate over lifesaving benefit of screening mammography continues.
    Arch Intern Med. 2012;172:446-7.
    PubMed     Text format     Related articles   


  10. COSTANZA ME
    Screening mammograms should not be underestimated.
    Arch Intern Med. 2012;172:446.
    PubMed     Text format     Related articles   



    BMC Cancer

  11. SU F PROF , Gu R Dr, Jia W M D, Zeng Y Dr, et al
    A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort study.
    BMC Cancer. 2012;12:161.
    PubMed     Text format     Related articles    Abstract available



    BMJ

  12. KESSON EM , Allardice GM, George WD, Burns HJ, et al
    Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women.
    BMJ. 2012;344:e2718.
    PubMed     Text format     Related articles    Abstract available



    Br J Cancer

  13. ALI HR , Dawson SJ, Blows FM, Provenzano E, et al
    Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer.
    Br J Cancer. 2012 Apr 26. doi: 10.1038/bjc.2012.
    PubMed     Text format     Related articles    Abstract available


  14. PAYNE RE , Wang F, Su N, Krell J, et al
    Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients.
    Br J Cancer. 2012 Apr 26. doi: 10.1038/bjc.2012.
    PubMed     Text format     Related articles    Abstract available



    Breast Cancer Res

  15. NADAL RM , Fernandez A, Sanchez-Rovira P, Salido M, et al
    Biomarkers Characterization of Circulating Tumour Cells in Breast Cancer Patients.
    Breast Cancer Res. 2012;14:R71.
    PubMed     Text format     Related articles    Abstract available


  16. FERNANDEZ-CUESTA L , Oakman C, Falagan-Lotsch P, Smoth KS, et al
    Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane based adjuvant therapy: results from the BIG 02-98 phase III trial.
    Breast Cancer Res. 2012;14:R70.
    PubMed     Text format     Related articles    Abstract available


  17. BORAS-GRANIC K , Wysolmerski JJ
    PTHrP and breast cancer: more than hypercalcemia and bone metastases.
    Breast Cancer Res. 2012;14:307.
    PubMed     Text format     Related articles    Abstract available


  18. JANKOWITZ RC , Brufsky AM
    Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term.
    Breast Cancer Res. 2012;14:308.
    PubMed     Text format     Related articles    Abstract available


  19. TSENG LM , Liu CY, Chang KC, Chu PY, et al
    CIP2A is a target of bortezomib in human triple negative breast cancer cells.
    Breast Cancer Res. 2012;14:R68.
    PubMed     Text format     Related articles    Abstract available



    Breast Cancer Res Treat

  20. DEBEB BG , Cohen EN, Boley K, Freiter EM, et al
    Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.
    Breast Cancer Res Treat. 2012.
    PubMed     Text format     Related articles    Abstract available


  21. LI T , Guo M, Gradishar WJ, Sparano JA, et al
    A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103).
    Breast Cancer Res Treat. 2012.
    PubMed     Text format     Related articles    Abstract available


  22. NAROD SA , Valentini A, Nofech-Mozes S, Sun P, et al
    Tumour characteristics among women with very low-risk breast cancer.
    Breast Cancer Res Treat. 2012.
    PubMed     Text format     Related articles    Abstract available



    Cancer

  23. LIN NU , Vanderplas A, Hughes ME, Theriault RL, et al
    Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.
    Cancer. 2012 Apr 27. doi: 10.1002/cncr.27581.
    PubMed     Text format     Related articles    Abstract available



    Cancer Cell

  24. MURANEN T , Selfors LM, Worster DT, Iwanicki MP, et al
    Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells.
    Cancer Cell. 2012;21:227-39.
    PubMed     Text format     Related articles    Abstract available


  25. CHAUDHARY A , Hilton MB, Seaman S, Haines DC, et al
    TEM8/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types.
    Cancer Cell. 2012;21:212-26.
    PubMed     Text format     Related articles    Abstract available



    Cancer Epidemiol Biomarkers Prev

  26. STONE J , Dite GS, Giles GG, Cawson J, et al
    Inference about causation from examination of familial confounding: application to longitudinal twin data on mammographic density measures that predict breast cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2012.
    PubMed     Text format     Related articles    Abstract available


  27. MA X , Beeghly-Fadiel A, Lu W, Shi J, et al
    Pathway analyses identify TGFBR2 as potential breast cancer susceptibility gene: results from a consortium study among Asians.
    Cancer Epidemiol Biomarkers Prev. 2012.
    PubMed     Text format     Related articles    Abstract available



    Cancer Lett

  28. SMALLEY M , Piggott L, Clarkson R
    Breast cancer stem cells: obstacles to therapy.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available


  29. TSUNASHIMA R , Naoi Y, Kishi K, Baba Y, et al
    Estrogen Receptor Positive Breast Cancer Identified by 95-Gene Classifier as at High Risk for Relapse Shows Better Response to Neoadjuvant Chemotherapy.
    Cancer Lett. 2012.
    PubMed     Text format     Related articles    Abstract available



    Clin Cancer Res

  30. O'HARA J , Vareslija D, McBryan J, Bane FT, et al
    AIB1:ERalpha transcriptional activity is selectively enhanced in AI-resistant breast cancer cells.
    Clin Cancer Res. 2012.
    PubMed     Text format     Related articles    Abstract available



    Eur J Cancer

  31. LIM SP , Wong NC, Suetani RJ, Ho K, et al
    Specific-site methylation of tumour suppressor ANKRD11 in breast cancer.
    Eur J Cancer. 2012.
    PubMed     Text format     Related articles    Abstract available



    Int J Cancer

  32. MA J , Luo DX, Huang C, Shen Y, et al
    AKR1B10 overexpression in breast cancer: association with tumor size, lymph node metastasis and patient survival and its potential as a novel serum marker.
    Int J Cancer. 2012 Apr 26. doi: 10.1002/ijc.27618.
    PubMed     Text format     Related articles    Abstract available



    Int J Oncol

  33. OUELAA-BENSLAMA R , De Wever O, Hendrix A, Sabbah M, et al
    Identification of a GalphaGbetagamma, AKT and PKCalpha signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition.
    Int J Oncol. 2012 Apr 30. doi: 10.3892/ijo.2012.1457.
    PubMed     Text format     Related articles    Abstract available



    Int J Radiat Oncol Biol Phys

  34. NGUYEN BT , Deb S, Fox S, Hill P, et al
    A Prospective Pathologic Study to Define the Clinical Target Volume for Partial Breast Radiation Therapy in Women With Early Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available


  35. MALUTA S , Dall'oglio S, Marciai N, Gabbani M, et al
    Accelerated Partial Breast Irradiation Using Only Intraoperative Electron Radiation Therapy in Early Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2012.
    PubMed     Text format     Related articles    Abstract available



    J Biol Chem

  36. NIN V , Escande C, Chini CC, Giri S, et al
    Role of deleted in breast cancer 1 (DBC1) in SIRT1 activation induced by protein kinase A and AMP activated protein kinase.
    J Biol Chem. 2012.
    PubMed     Text format     Related articles    Abstract available


  37. NIU J , Shi Y, Tan G, Yang CH, et al
    DNA damage induces NF-kappaB-dependent microRNA-21 upregulation and promotes breast cancer cell invasion.
    J Biol Chem. 2012.
    PubMed     Text format     Related articles    Abstract available


  38. TARRAGONA M , Pavlovic M, Arnal-Estape A, Urosevic J, et al
    Identification of NOG as a specific breast cancer bone metastasis-supporting gene.
    J Biol Chem. 2012.
    PubMed     Text format     Related articles    Abstract available



    J Clin Oncol

  39. DI LEO A , Malorni L
    Polyendocrine Treatment in Estrogen Receptor-Positive Breast Cancer: A "FACT" Yet to Be Proven.
    J Clin Oncol. 2012.
    PubMed     Text format     Related articles   



    J Natl Cancer Inst

  40. CHUBAK J , Yu O, Pocobelli G, Lamerato L, et al
    Administrative Data Algorithms to Identify Second Breast Cancer Events Following Early-Stage Invasive Breast Cancer.
    J Natl Cancer Inst. 2012.
    PubMed     Text format     Related articles    Abstract available


  41. SINHA G
    Pregnancy After Breast Cancer Appears Safe.
    J Natl Cancer Inst. 2012.
    PubMed     Text format     Related articles   


  42. KELLY CM , Pritchard KI
    CYP2D6 genotype as a marker for benefit of adjuvant tamoxifen in postmenopausal women: lessons learned.
    J Natl Cancer Inst. 2012;104:427-8.
    PubMed     Text format     Related articles   



    JAMA

  43. SMITH GL , Xu Y, Buchholz TA, Giordano SH, et al
    Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer.
    JAMA. 2012;307:1827-37.
    PubMed     Text format     Related articles    Abstract available



    Lancet

  44. KRIEGER N , Bassett MT, Gomez SL
    Breast and cervical cancer in 187 countries between 1980 and 2010.
    Lancet. 2012;379:1391-2.
    PubMed     Text format     Related articles   


  45. FERLAY J , Forman D, Mathers CD, Bray F, et al
    Breast and cervical cancer in 187 countries between 1980 and 2010.
    Lancet. 2012;379:1390-1.
    PubMed     Text format     Related articles   



    N Engl J Med

  46. TARTARONE A , Lerose R, Aieta M
    Everolimus in HR-positive advanced breast cancer.
    N Engl J Med. 2012;366:1739.
    PubMed     Text format     Related articles   


  47. MASSARWEH S , Croley J, Weiss H
    Everolimus in HR-positive advanced breast cancer.
    N Engl J Med. 2012;366:1738-9.
    PubMed     Text format     Related articles   



    Oncogene

  48. BAMBANG IF , Lee YK, Richardson DR, Zhang D, et al
    Endoplasmic reticulum protein 29 regulates epithelial cell integrity during the mesenchymal-epithelial transition in breast cancer cells.
    Oncogene. 2012 Apr 30. doi: 10.1038/onc.2012.
    PubMed     Text format     Related articles    Abstract available


  49. LAW ME , Corsino PE, Jahn SC, Davis BJ, et al
    Glucocorticoids and histone deacetylase inhibitors cooperate to block the invasiveness of basal-like breast cancer cells through novel mechanisms.
    Oncogene. 2012 Apr 30. doi: 10.1038/onc.2012.
    PubMed     Text format     Related articles    Abstract available



    Oncol Rep

  50. GLYNN RW , Miller N, Mahon S, Kerin MJ, et al
    Expression levels of HER2/neu and those of collocated genes at 17q12-21, in breast cancer.
    Oncol Rep. 2012 Apr 23. doi: 10.3892/or.2012.1780.
    PubMed     Text format     Related articles    Abstract available


  51. LI XL , Xu JH, Nie JH, Fan SJ, et al
    Exogenous expression of UHRF1 promotes proliferation and metastasis of breast cancer cells.
    Oncol Rep. 2012 Apr 30. doi: 10.3892/or.2012.1792.
    PubMed     Text format     Related articles    Abstract available



    Oncology

  52. WITZEL I , Schroder C, Muller V, Zander H, et al
    Detection of Activated Leukocyte Cell Adhesion Molecule in the Serum of Breast Cancer Patients and Implications for Prognosis.
    Oncology. 2012;82:305-312.
    PubMed     Text format     Related articles    Abstract available



    PLoS One

  53. DU J , Zhou N, Liu H, Jiang F, et al
    Arsenic Induces Functional Re-Expression of Estrogen Receptor alpha by Demethylation of DNA in Estrogen Receptor-Negative Human Breast Cancer.
    PLoS One. 2012;7:e35957.
    PubMed     Text format     Related articles    Abstract available


  54. STAIGER C , Cadot S, Kooter R, Dittrich M, et al
    A critical evaluation of network and pathway-based classifiers for outcome prediction in breast cancer.
    PLoS One. 2012;7:e34796.
    PubMed     Text format     Related articles    Abstract available


  55. MAJUMDER M , Tutunea-Fatan E, Xin X, Rodriguez-Torres M, et al
    Co-Expression of alpha9beta1 Integrin and VEGF-D Confers Lymphatic Metastatic Ability to a Human Breast Cancer Cell Line MDA-MB-468LN.
    PLoS One. 2012;7:e35094.
    PubMed     Text format     Related articles    Abstract available



    Radiology

  56. KONG CY , Lee JM, McMahon PM, Lowry KP, et al
    Using radiation risk models in cancer screening simulations: important assumptions and effects on outcome projections.
    Radiology. 2012;262:977-84.
    PubMed     Text format     Related articles    Abstract available



Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: